(MedPage Today) — The FDA has officially eliminated clozapine’s risk evaluation and mitigation strategy (REMS) program, with all REMS operations stopped as of June 13.
The announcement comes several months after a joint FDA advisory committee…
Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/116119
Author :
Publish date : 2025-06-17 18:53:00
Copyright for syndicated content belongs to the linked Source.
